Literature DB >> 25302237

Predictors of success of medical management of ectopic pregnancy in a tertiary care hospital in United arab emirates.

Pooja Rajesh Vaswani1.   

Abstract

INTRODUCTION: Ectopic pregnancy is the most common cause of pregnancy related deaths in the first trimester of pregnancy. Advances in laboratory and imaging technologies in last few decades allow an early diagnosis of ectopic pregnancy, many times even before the patient develops any symptoms. Consequently in many such patients surgery is not always necessary. Expectant and medical management are feasible options in properly selected cases. In the present study, efficacy of medical management of selected cases of ectopic pregnancy with injection methotrexate and the factors influencing the success of medical management were evaluated.
MATERIALS AND METHODS: Retrospective study involving 40 women with ectopic pregnancy who met inclusion criteria and were managed medically with Methotrexate (MTX) in a tertiary hospital in United Arab Emirates (UAE). Various factors which could possibly influence the success of medical management were evaluated.
RESULTS: ROC analyses for day 1(pretreatment) Beta HCG levels revealed that the optimum cut off for Beta HCG level of 6000 mIU/ml on day 1 can be considered a good predictor of success of medical management with MTX. Falling serum Beta HCG between day 1-4 very well predicted success of MTX therapy (irrespective of number of doses of MTX) with a positive predictive value (PPV) of 100% and negative predictive value (NPV) of 31.25%. Similarly adnexal mass size ≤ 3 cms and duration of amenorrhoea < 6 weeks were found to be good predictors of success of medical management (PPV 96.66% and NPV 90% for both factors).In the present study, irrespective of number of doses received, medical management with MTX was successful in 75% cases (30 out of 40).
CONCLUSION: RESULTS of this study indicate that pretreatment Beta HCG level of < 6000 mIU/ml, adnexal mass size < 3 cms, amenorrhoea < 6 weeks and absence of free fluid in the pelvis are predictors of a successful treatment with MTX. In properly selected cases medical management of ectopic pregnancy with MTX is highly effective and can be considered a forward step taken towards conservation of fallopian tubes especially in countries like UAE where there is inclination towards large family size based on religious and cultural background.

Entities:  

Keywords:  Beta HCG; Ectopic pregnancy; Medical management; Methotrexate

Year:  2014        PMID: 25302237      PMCID: PMC4190761          DOI: 10.7860/JCDR/2014/8152.4712

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  Serum progesterone as a predictor of methotrexate success in the treatment of ectopic pregnancy.

Authors:  M X Ransom; A J Garcia; M Bohrer; G H Corsan; E Kemmann
Journal:  Obstet Gynecol       Date:  1994-06       Impact factor: 7.661

2.  Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate.

Authors:  G H Lipscomb; D Bran; M L McCord; J C Portera; F W Ling
Journal:  Am J Obstet Gynecol       Date:  1998-06       Impact factor: 8.661

3.  Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy.

Authors:  P J Hajenius; S Engelsbel; B W Mol; F Van der Veen; W M Ankum; P M Bossuyt; D J Hemrika; F B Lammes
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Predictors of treatment failure for ectopic pregnancy treated with single-dose methotrexate.

Authors:  A Tawfiq; A F Agameya; P Claman
Journal:  Fertil Steril       Date:  2000-11       Impact factor: 7.329

5.  Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience.

Authors:  C S Stika; L Anderson; M C Frederiksen
Journal:  Am J Obstet Gynecol       Date:  1996-06       Impact factor: 8.661

6.  Medical treatment of ectopic pregnancy: a ten-year review of 106 cases at Maharaj Nakorn Chiang Mai Hospital.

Authors:  Karnchana Srivichai; Chumnong Uttavichai; Theera Tongsong
Journal:  J Med Assoc Thai       Date:  2006-10

7.  Efficacy and safety of single-dose systemic methotrexate in the treatment of ectopic pregnancy.

Authors:  J L Glock; J V Johnson; J R Brumsted
Journal:  Fertil Steril       Date:  1994-10       Impact factor: 7.329

8.  Identification of hormonal parameters for successful systemic single-dose methotrexate therapy in ectopic pregnancy.

Authors:  G H Corsan; M Karacan; S Qasim; M K Bohrer; M X Ransom; E Kemmann
Journal:  Hum Reprod       Date:  1995-10       Impact factor: 6.918

9.  Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study.

Authors:  Monika Skubisz; Philip Dutton; William Colin Duncan; Andrew W Horne; Stephen Tong
Journal:  BMC Pregnancy Childbirth       Date:  2013-02-01       Impact factor: 3.007

10.  Predictors of success of repeated injections of single-dose methotrexate regimen for tubal ectopic pregnancy.

Authors:  Geum Joon Cho; Sang Hoon Lee; Jin Woo Shin; Nak Woo Lee; Tak Kim; Hai Joong Kim; Kyu Wan Lee
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more
  2 in total

1.  Predicting factors of medical treatment success with single dose methotrexate in tubal ectopic pregnancy: a retrospective study.

Authors:  Fariba Mirbolouk; Azadeh Yousefnezhad; Atefeh Ghanbari
Journal:  Iran J Reprod Med       Date:  2015-06

2.  Predictive factors of methotrexate treatment success in ectopic pregnancy: A single-center tertiary study.

Authors:  Cigdem Pulatoglu; Ozan Dogan; Alper Basbug; Aski Ellibes Kaya; Ahmet Yildiz; Osman Temizkan
Journal:  North Clin Istanb       Date:  2018-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.